References
- Wolf LD, Hozack W, Rothman RH. Pulmonary embolism in total joint arthroplasty. Clin Orthop 1993;288:219–33.
- Warwick D, Williams MH, Bannister GC. Death and thromboem-bolic disease after total hip replacement. J Bone Joint Surg 1995; 77B:6–10.
- Trowbridge A, Boese CK, Woodruff B, Brindley HH Sr, Lowry W, Spiro T. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty: a pilot study. Clin Orthop 1993;299:203–8.
- Yamazaki T, Hamaguchi M, Takamatsu J, Okamoto Y, Katsumi A, Kagami K, et al. Analysis for heterozygosity of protein S mFtNA: application to genetic screening and family studies in he-reditary protein S deficiency. Int J Hematol 1996;64:119–25.
- Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990;29: 7845–52.
- Dahlback B. Protein S and C4b-binding protein: components in-volved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991;66:49–61.
- Van Hinsbergh VWM, Bertyina RM, Wijngaarden A, Van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasmi-nogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985;65:444–51.
- Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw, et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990;76: 538–48.
- Kamiya T, Sugihara T, Ogata K, Saito H, Suzuki K, Nishioka J, et al. Inherited deficiency of protein S in a Japanese family with recurrent venous thrombosis: a study of three generations. Blood 1986;67:406–10.
- Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic pa-tients with protein C and protein S deficiency: a prospective cohort study. Thromb Haemost 1994;71:441–5.
- Cooper DN. Human gene mutations affecting RNA processing and translation. Ann Med 1993;25:11–7.
- Sacchi E, Pinotti M, Marchetti G, Merati G, Tagliabue L, Mannucci PM, et al. Protein S mRNA in patients with protein S deficiency. Thromb Haemost 1995;73:746–9.
- Laupacis A. The frequency of venous thrombosis in cemented and non-cemented hip arthroplasty. J Bone Joint Surg 1996;78B:210–2.
- Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery: risk factors, prophylaxis and diagnosis. Clin Orthop 1989;242:212–31.
- Coventry MB, Nolan DR, Beckenbaugh RD. Delayed prophylac-tic anticoagulation: a study of results and complications in 2012 total hip arthroplasties. J Bone Joint Surg 1973;55A:1487–92.
- Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop 1977;127:123–32.
- Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thrombolism after total hip replace-ment. N Engl J Med 1996;335:697–700.
- Planes A, Vochelle N, Darmon J-Y, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348:224–8.
- Havig O. Deep vein thrombosis and pulmonary embolism: an au-topsy study with multiple regression analysis of possible risk fac-tors. Acta Chir Scand Suppl 1977;478.
- Michiels JJ, Stibbel J, Bertina R, Broekmans A. Effectiveness of long term oral anticoagulant treatment in preventing venous thrombosis in hereditary protein S deficiency. BMJ 1987;296: 641–3.